Get the Stockscreener App
7.22
6.96%
0.47
After Hours:
7.11
-0.11
-1.52%
Electrocore Inc stock is traded at $7.22, with a volume of 41,507.
It is up +6.96% in the last 24 hours and up +19.34% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$6.75
Open:
$6.85
24h Volume:
41,507
Relative Volume:
3.47
Market Cap:
$43.87M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-1.5392
EPS:
-4.6906
Net Cash Flow:
$-14.87M
1W Performance:
+13.70%
1M Performance:
+19.34%
6M Performance:
+17.02%
1Y Performance:
+18.95%
1-Day Range:
$6.76
$7.4562
1-Week Range:
$6.4095
$7.4562
52-Week Range:
$4.90
$8.08
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore to Participate in Upcoming Investor Conferences - GlobeNewswire
electroCore to Participate in Upcoming Investor Conferences - StockTitan
Vagus Nerve Stimulators Market Outlook by Examining the Results - openPR
electroCore (NASDAQ:ECOR) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey - Defense World
electroCore Engages FNK IR to Execute Expanded Investor Relations Program - GlobeNewswire
electroCore Engages FNK IR to Execute Expanded Investor Relations Program - StockTitan
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) - GlobeNewswire
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training - StockTitan
Vagus Nerve Stimulators Market Report, Size, Share & Outlook - openPR
ElectroCore Announces CFO Transition and Shareholder Meeting Outcomes - TipRanks
We Think electroCore (NASDAQ:ECOR) Can Afford To Drive Business Growth - Yahoo Finance
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
electroCore, Inc. (NASDAQ:ECOR) Short Interest Up 20.1% in August - Defense World
Vagus Nerve Stimulators Industry to Witness Massive Growth - openPR
electroCore, Inc. (NASDAQ:ECOR) Director Thomas J. Errico Buys 5,000 Shares of Stock - Defense World
ElectroCORE Debuts TAC-STIM - MPO-mag
Q3 2024 EPS Estimates for electroCore, Inc. Increased by Brookline Capital Management (NASDAQ:ECOR) - Defense World
electroCore Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
ECORelectroCore, Inc. Latest Stock News & Market Updates - StockTitan
electroCore to Participate in Upcoming Investor Conferences - Yahoo Finance
ElectroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - MSN
ElectroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Finance
electroCore Announces Second Quarter 2024 Financial Results - GlobeNewswire
electroCore Announces Second Quarter 2024 Financial Results - StockTitan
electroCore (ECOR) to Release Earnings on Wednesday - Defense World
electroCore Insiders Added US$653.5k Of Stock To Their Holdings - Yahoo Finance
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - StockTitan
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning - GlobeNewswire
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning - StockTitan
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - GlobeNewswire
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - StockTitan
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - Yahoo Finance
Transcutaneous Neurostimulators Industry to Witness an Outstanding Growth by 2034 |, ElectroCore Medical, NEUROMetrix, N – KnowCasino - KnowCasino
Vagus Nerve Stimulators Market Huge Growth in Future Scope - openPR
electroCore Announces Board Reclassification and Consulting Deal By Investing.com - Investing.com Canada
electroCore Announces Board Reclassification and Consulting Deal - Investing.com
Electrocore Director’s Term Extended and New Consulting Role - TipRanks
Cluster Headache Market to See Booming Growth 2024-2031 | - openPR
Vagus Nerve Stimulators Market Expected to Expand at a Steady - openPR
SEC Form S-1 filed by electroCore Inc. - Quantisnow
electroCore announces commercial launch of TAC-STIM - TipRanks
Future Outlook and Predictions for the Vagus Nerve Stimulators Market Expected to Expand at a steady 2024-2031 - openPR
electroCore, Inc. (NASDAQ:ECOR) Position Boosted by International Assets Investment Management LLC - Defense World
electroCore Announces the Commercial Launch of TAC-STIM™Upgraded TAC-STIM enhances Energy, Focus and ... - BioSpace
electroCore Announces the Commercial Launch of TAC-STIM™ - GlobeNewswire
electroCore Announces the Commercial Launch of TAC-STIM™ - Morningstar
electroCore, Inc.'s (NASDAQ:ECOR) Path To Profitability - Yahoo Finance
electroCore to Announce First Quarter Financial Results on Wednesday, May 3 - Quantisnow
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):